AUG 11, 2026 · JOURNAL ARTICLE
Case Report: Primed dendritic cell immunotherapy for multiple solid tumors
Frontiers in Immunology
Retrospective case series of five patients with durable complete responses to dendritic cell therapy, but uncontrolled, single-centre design with no comparator limits strength; observations merit larger trials but cannot establish efficacy or guide practice alone.
Reported
Sample size5
Median age51 years
Age range39–62 years